<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03210675</url>
  </required_header>
  <id_info>
    <org_study_id>DP-TRS-T21</org_study_id>
    <nct_id>NCT03210675</nct_id>
  </id_info>
  <brief_title>Early Detection and Treatment of Respiratory Sleep Disorders in Children With Down Syndrome</brief_title>
  <acronym>RESPIRE21</acronym>
  <official_title>Early Detection and Treatment of Respiratory Sleep Disorders in Children With Down Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Jerome Lejeune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hôpital Necker-Enfants Malades</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Jerome Lejeune</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, comparative, open label, single-center study to demonstrate that an early
      (from 6 months of age) and systematic (every 6 months) screening of Obstructive Sleep Apnea
      (OSA) by polysomnography (PSG) in children with Down Syndrome during the first 3 years of
      life is associated with an improved neurocognitive development at the age of 3 years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 31, 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Interventional, comparative, open label, multi-center study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Griffith Mental Development Scale (GMDS) scores</measure>
    <time_frame>At the age of 3 years</time_frame>
    <description>Mean Griffith Mental Development Scale (GMDS) scores at the age of 3 years will be compared between the 2 groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Down Syndrome</condition>
  <condition>Obstructive Sleep Apnea of Newborn</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Will have a PSG at home every 6 months (± 1 month) from the age of 6 months until the age of 3 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Will have a single PSG at home which will give a reference in the Down Syndrome population of 3 years old and will be used as reference to the study group</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Polysomnography (PSG)</intervention_name>
    <description>PSG will be perfomed every 6 months in the Study group from the age of 6 months to 3 years</description>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_label>Standard Care Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria :

        Down Syndrome Age 6 months or less for the Study Group Age 30 to 36 months for the Standard
        Care Group Living in Paris or Paris area (75, 77, 78, 92, 93, 94, 95) Parents or legal
        representative agreeing with the study requirements and able to understand, date and sign
        the informed consent form before study enrollment French language is native mother tongue

        Exclusion criteria :

        Gestationnel age &lt; 36 completed amenorrhoea weeks Patient who have or had acute CNS
        suffering signs Patients with Down Syndrome already had continuous positive airway pressure
        treatment for OSA Patients participating in another clinical study or for whom a
        participation to another biomedical research is expected before the end or their follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brigitte FAUROUX, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Necker-Enfants Malade</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle MAREY, PI</last_name>
    <phone>+33 1 56 58 63 00</phone>
    <email>isabelle.marey@institutlejeune.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hervé WALTI</last_name>
    <phone>+33 1 56 58 63 00</phone>
    <email>herve.walti@institutlejeune.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut Jérome Lejeune</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Rakic</last_name>
      <phone>01 56 58 63 00</phone>
      <email>contatct@institutlejeune.org</email>
    </contact>
    <investigator>
      <last_name>Isabelle Marey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hervé Walti, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aimé Ravel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clotilde Mircher, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile Cieuta-Walti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanne Toulas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.institutlejeune.org/</url>
    <description>Sponsor and site investigator</description>
  </link>
  <link>
    <url>http://vnietsommeil.aphp.fr/</url>
    <description>Site investigator for PSG evaluation</description>
  </link>
  <reference>
    <citation>Lal C, White DR, Joseph JE, van Bakergem K, LaRosa A. Sleep-disordered breathing in Down syndrome. Chest. 2015 Feb;147(2):570-579. doi: 10.1378/chest.14-0266. Review.</citation>
    <PMID>25644910</PMID>
  </reference>
  <reference>
    <citation>Bertrand P, Navarro H, Caussade S, Holmgren N, Sánchez I. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol. 2003 Aug;36(2):137-41.</citation>
    <PMID>12833493</PMID>
  </reference>
  <reference>
    <citation>Fricke BL, Donnelly LF, Shott SR, Kalra M, Poe SA, Chini BA, Amin RS. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006 Jun;36(6):518-23. Epub 2006 Apr 5.</citation>
    <PMID>16596369</PMID>
  </reference>
  <reference>
    <citation>Shires CB, Anold SL, Schoumacher RA, Dehoff GW, Donepudi SK, Stocks RM. Body mass index as an indicator of obstructive sleep apnea in pediatric Down syndrome. Int J Pediatr Otorhinolaryngol. 2010 Jul;74(7):768-72. doi: 10.1016/j.ijporl.2010.03.050. Epub 2010 May 7.</citation>
    <PMID>20452066</PMID>
  </reference>
  <reference>
    <citation>Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, Schechter MS, Ward SD, Sheldon SH, Shiffman RN, Lehmann C, Spruyt K; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):e714-55. doi: 10.1542/peds.2012-1672. Epub 2012 Aug 27. Review.</citation>
    <PMID>22926176</PMID>
  </reference>
  <reference>
    <citation>Breslin J, Spanò G, Bootzin R, Anand P, Nadel L, Edgin J. Obstructive sleep apnea syndrome and cognition in Down syndrome. Dev Med Child Neurol. 2014 Jul;56(7):657-64. doi: 10.1111/dmcn.12376. Epub 2014 Jan 29.</citation>
    <PMID>24471822</PMID>
  </reference>
  <reference>
    <citation>Bull MJ; Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics. 2011 Aug;128(2):393-406. doi: 10.1542/peds.2011-1605. Epub 2011 Jul 25. Erratum in: Pediatrics. 2011 Dec;128(6):1212.</citation>
    <PMID>21788214</PMID>
  </reference>
  <reference>
    <citation>Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R, Pumphrey R, Ani C, Davies S, Edwards V, Green H, Salt A, Logan S. Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial. BMJ. 2008 Mar 15;336(7644):594-7. doi: 10.1136/bmj.39465.544028.AE. Epub 2008 Feb 21.</citation>
    <PMID>18296460</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

